Gene · 1399
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes. | Int J Mol Sci | 2023 | 37373090 | PubTator, text mining | PubMed |
| The Way to Malignant Transformation: Can Epigenetic Alterations Be Used to Diagnose Early-Stage Head and Neck Cancer? | Biomedicines | 2023 | 37371812 | PubTator, text mining | PubMed |
| Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies. | J Pathol | 2023 | 37350195 | PubTator, text mining | PubMed |
| Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling. | Nat Commun | 2023 | 37336884 | PubTator, text mining | PubMed |
| Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3. | Nat Commun | 2023 | 37336883 | PubTator, text mining | PubMed |
| Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo. | Front Pharmacol | 2023 | 37324449 | PubTator, text mining | PubMed |
| Identification of potential biomarkers to predict organ morbidity in COVID-19: A repository based proteomics perspective. | Biochem Biophys Rep | 2023 | 37304132 | PubTator, text mining | PubMed |
| SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness? | Int J Mol Sci | 2023 | 37298304 | PubTator, text mining | PubMed |
| The Structural Dynamics, Complexity of Interactions, and Functions in Cancer of Multi-SAM Containing Proteins. | Cancers (Basel) | 2023 | 37296980 | PubTator, text mining | PubMed |
| HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies. | Cancers (Basel) | 2023 | 37296866 | PubTator, text mining | PubMed |
| Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial). | Int J Surg | 2023 | 37288582 | PubTator, text mining | PubMed |
| Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion. | Sci Rep | 2023 | 37280243 | PubTator, text mining | PubMed |
| CD34-Structure, Functions and Relationship with Cancer Stem Cells. | Medicina (Kaunas) | 2023 | 37241170 | PubTator, text mining | PubMed |
| Crosstalk between miRNAs and DNA Methylation in Cancer. | Genes (Basel) | 2023 | 37239435 | PubTator, text mining | PubMed |
| Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families. | J Cell Sci | 2023 | 37232246 | PubTator, text mining | PubMed |
| Systemic lupus erythematosus: latest insight into etiopathogenesis. | Rheumatol Int | 2023 | 37226016 | PubTator, text mining | PubMed |
| Stabilization of MYC G-quadruplex DNA by ruthenium (II) complex overcomes imatinib resistance in chronic myeloid leukemia cells harboring T315I mutation. | Genes Dis | 2023 | 37223538 | PubTator, text mining | PubMed |
| Dysregulated MicroRNAs in the Pathogenesis of Systemic Lupus Erythematosus: A Comprehensive Review. | Int J Biol Sci | 2023 | 37215992 | PubTator, text mining | PubMed |
| Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A. | J Cancer | 2023 | 37215441 | PubTator, text mining | PubMed |
| Identification of RAC1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencing. | Cell Death Dis | 2023 | 37202394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1399/papers?page=9